COVID-19 Vaccine Production Facility Failures
2021-05-19T19:12:01-04:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvYmM1XC8yMDIxMDUxOTExMDY1NTAxNF9oZC5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Emergent BioSolutions executives testified before the House Coronavirus Select Subcommittee about failures at their facility being used to produce Johnson and Johnson and AstraZeneca COVID-19 vaccines. Emergent President and CEO Robert Kramer said a mixup occurred, because the facility was was producing the two vaccines simultaneosuly, which he called “unprecedented.” Mr. Kramer testified the contamination impacted about 15 million doses of the Johnson & Johnson vaccine. He spoke about remediation and said Emergent would be prepared to begin production “within a matter of days.” Also participating was Emergent Founder and Executive Chair Faud El-Hibri. The two faced questions about the origins of the company’s federal contract, executive compensation and Emergent stock sales, the number of COVID-19 vaccines the company had delivered to date, and the importance of intellectual property protections.
Emergent BioSolutions executives testified before the House Coronavirus Select Subcommittee about failures at their facility being used to p… read more
Emergent BioSolutions executives testified before the House Coronavirus Select Subcommittee about failures at their facility being used to produce Johnson and Johnson and AstraZeneca COVID-19 vaccines. Emergent President and CEO Robert Kramer said a mixup occurred, because the facility was was producing the two vaccines simultaneosuly, which he called “unprecedented.” Mr. Kramer testified the contamination impacted about 15 million doses of the Johnson & Johnson vaccine. He spoke about remediation and said Emergent would be prepared to begin production “within a matter of days.” Also participating was Emergent Founder and Executive Chair Faud El-Hibri. The two faced questions about the origins of the company’s federal contract, executive compensation and Emergent stock sales, the number of COVID-19 vaccines the company had delivered to date, and the importance of intellectual property protections. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
Hosting Organization
Purchase a Download
COVID-19 Vaccine Production Facility Failures
-
MP4 video - Standard
- Price:
- $9.99 or Free with MyC‑SPAN
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
House Select Coronavirus Crisis Subcommittee Hearing on the Pandemic Response
Dr. Anthony Fauci and Centers for Disease Control and Prevention Director Dr. Rochelle Walensky were among the witnesses…
-
Oversight Hearing on Fraud in COVID-19 Small Business Relief Programs
The House Select Subcommittee on the Coronavirus Pandemic held a hearing on waste, fraud and abuse that occurred during …
-
House Coronavirus Crisis Subcommittee Briefing on Vaccines
The House Select Subcommittee on the Coronavirus Crisis heard from community leaders about the pandemic’s impact on comm…
-
Health and Human Services Secretary Testimony on COVID-19 Response
Health and Human Services Secretary Alex Azar testified before the House Select Subcommittee on the Coronavirus Crisis. …
User Created Clips from This Video
-
- 5 minutes
- 40 views
-
- 5 minutes
- 39 views
-
- 5 minutes
- 30 views
-
- 5 minutes
- 11 views